| DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma (NCT03905902) | SOTIO a.s. | 2021-08-01 |
| Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy (NCT04415944) | Wake Forest University Health Sciences | 2021-05-20 |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer (NCT04158349) | University of Utah | 2021-03-22 |
| Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (NCT04498117) | CanariaBio Inc. | 2020-08-25 |
| A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors (NCT04442126) | Numab Therapeutics AG | 2020-08-19 |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC (NCT03732781) | Oncoinvent Solutions AS | 2020-05-27 |
| A Trial Evaluating TG4050 in Ovarian Carcinoma. (NCT03839524) | Transgene | 2019-12-09 |
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum (NCT04022213) | Memorial Sloan Kettering Cancer Center | 2019-07-15 |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy (NCT03593681) | Boston Scientific Corporation | 2018-08-27 |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) (NCT03931304) | Hospices Civils de Lyon | 2018-02-01 |
| Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 (NCT03296826) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2017-11-08 |
| Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer (NCT03056833) | Ronald Buckanovich | 2017-06-10 |
| CAR T Cells in Mesothelin Expressing Cancers (NCT03054298) | University of Pennsylvania | 2017-04-06 |
| Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia (NCT04001023) | Turku University Hospital | 2017-03-09 |
| Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT02199171) | University of California, Irvine | 2014-07-01 |
| Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer (NCT02125513) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2014-01-01 |
| (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma (NCT01936974) | Western Regional Medical Center | 2013-09-01 |
| Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer (NCT03480750) | National Cheng-Kung University Hospital | 2012-09-01 |
| Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma (NCT01035658) | SCRI Development Innovations, LLC | 2010-01-01 |
| Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer (NCT00181688) | Massachusetts General Hospital | 2003-10-01 |
| Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer (NCT00047632) | InterMune | 2001-10-01 |